David Brown, Managing Director of CLEO Systems, has been invited to join the techUK Interoperability Working Group. techUK is a trade association which brings together people, companies and organisations to realise the positive outcomes of digital technology. It has over 800 members across the UK and creates a network for innovation and collaboration across business, government and stakeholders to provide a better future for people, society, the economy and the planet. CLEO Systems is a leading developer of innovative software solutions which support Urgent, Emergency and Outpatient care settings, and joined techUK in May 2021.
The Interoperability Working Group is made up of experienced techUK members from the world of health and care technology. The group has an ongoing programme of work, operating closely with organisations such as NHS England, INTEROPen and the PRSB. The group’s focus on digital health and care includes writing and launching the Interoperability Charter, first published by techUK in 2015, and updated in 2022.
CLEO’s goal is to make sure that clinicians, advisors and patients benefit from clinically safe and seamless patient management, real time clinical record updates, analytics dashboards, as well as interoperability with all primary care systems.
In 2022, the company rolled out CLEO CORE to wider urgent care settings and worked with Midlands Partnership NHS Foundation Trust (MPFT) and NHS Digital to implement CLEO SOLO EPS electronic prescription service, which proved to be a successful first-of-type outpatient secondary care pilot.
David Brown, Managing Director, CLEO Systems said, ‘It is a huge honour to be asked to represent CLEO Systems in the techUK Interoperability Working Group. I’m really excited to be able to share our knowledge of working in this area and collaborating with digital technology innovators. I'm proud to be part of an innovative team working with our customers and the wider NHS community on digital solutions that improve the working experience as well as create opportunities for change, and I’ll be looking forward to bringing this to the table. We also have the advantage of being part of a wider social enterprise, IC24, which means we benefit from our in-house clinicians and operational teams who aid us in optimising our solutions for the benefit of our users and patients.’